Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepali Kumar

Showing results (171-180 of 231) with videos related to

Pageof 24
Sort By:
Antiviral Therapy|April 1, 2017
Progressive multifocal leukoencephalopathy due to John Cunningham (JC) virus following allogeneic haematopoietic cell transplantationWilson Lam, Zeyad Al-Shaibani, Deepali Kumar, et al.
The Lancet. Infectious Diseases|June 23, 2023
Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patientsJavier T Solera, Matthew Ierullo, Berta G Arbol, et al.
Transplantation|January 16, 2010
A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipientsDeepali Kumar, Shahid Husain, Maggie Hong Chen, et al.
Transplantation|February 2, 2021
Evaluation of Recombinant Herpes Zoster Vaccine for Primary Immunization of Varicella-seronegative Transplant RecipientsArnaud G L'Huillier, Cedric Hirzel, Victor H Ferreira, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 3, 2025
Longitudinal Innate and Heterologous Adaptive Immune Responses to SARS-CoV-2 JN.1 in Transplant Recipients With Prior Omicron Infection: Limited Neutralization but Robust CD4<sup>+</sup> T-Cell ActivityVictor H Ferreira, Brandon Keith, Faranak Mavandadnejad, et al.
The Journal of Applied Laboratory Medicine|August 3, 2021
Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine ResponseAshley Di Meo, Jessica J Miller, Anselmo Fabros, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2009
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus diseaseOriol Manuel, Anders Asberg, Xiaoli Pang, et al.
The New England Journal of Medicine|August 11, 2021
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant RecipientsVictoria G Hall, Victor H Ferreira, Terrance Ku, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 14, 2012
Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapyVincent C Emery, Oriol Manuel, Anders Asberg, et al.
The Journal of Infectious Diseases|September 25, 2019
Cell-Mediated Immune Responses After Influenza Vaccination of Solid Organ Transplant Recipients: Secondary Outcomes Analyses of a Randomized Controlled TrialArnaud G L'huillier, Victor H Ferreira, Cedric Hirzel, et al.
Pageof 24

Showing results (171-180 of 231) with videos related to

Sort By:
Pageof 24
Antiviral Therapy|April 1, 2017
Progressive multifocal leukoencephalopathy due to John Cunningham (JC) virus following allogeneic haematopoietic cell transplantationWilson Lam, Zeyad Al-Shaibani, Deepali Kumar, et al.
The Lancet. Infectious Diseases|June 23, 2023
Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patientsJavier T Solera, Matthew Ierullo, Berta G Arbol, et al.
Transplantation|January 16, 2010
A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipientsDeepali Kumar, Shahid Husain, Maggie Hong Chen, et al.
Transplantation|February 2, 2021
Evaluation of Recombinant Herpes Zoster Vaccine for Primary Immunization of Varicella-seronegative Transplant RecipientsArnaud G L'Huillier, Cedric Hirzel, Victor H Ferreira, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 3, 2025
Longitudinal Innate and Heterologous Adaptive Immune Responses to SARS-CoV-2 JN.1 in Transplant Recipients With Prior Omicron Infection: Limited Neutralization but Robust CD4<sup>+</sup> T-Cell ActivityVictor H Ferreira, Brandon Keith, Faranak Mavandadnejad, et al.
The Journal of Applied Laboratory Medicine|August 3, 2021
Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine ResponseAshley Di Meo, Jessica J Miller, Anselmo Fabros, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2009
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus diseaseOriol Manuel, Anders Asberg, Xiaoli Pang, et al.
The New England Journal of Medicine|August 11, 2021
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant RecipientsVictoria G Hall, Victor H Ferreira, Terrance Ku, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 14, 2012
Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapyVincent C Emery, Oriol Manuel, Anders Asberg, et al.
The Journal of Infectious Diseases|September 25, 2019
Cell-Mediated Immune Responses After Influenza Vaccination of Solid Organ Transplant Recipients: Secondary Outcomes Analyses of a Randomized Controlled TrialArnaud G L'huillier, Victor H Ferreira, Cedric Hirzel, et al.
Pageof 24